Knowledge Center
We believe in sharing knowledge being a key to success.
In this section you will find published articles and essays authored by members of the team of ten23 health.
Articles
2024, March - Andrea Allmendinger, Philipp Behrendt and Hanns-Christian Mahler present the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.
2024, February - Andrea Allmendinger and Hanns-Christian Mahler present two case studies to illustrate the complexity of modern sterile product developments.
2024, February - Europe's Pioneering Leaders Shaping the Future of Healthcare. In this article, Euro Health Leaders Magazine features a portrait of ten23 health's CEO & Founder Prof. Dr. Hanns-Christian Mahler.
2024, February - ten23 health: Sustainable success. With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines.
2023, May - Intravitreal Injections - more than meets the eye: In this article, Andrea Allmendinger and Hanns-Christian Mahler highlight the technical challenges of intravitreal administration and considerations from the ophthalmologist’s and patient’s perspectives.
2023, March - Integrated Drug Product - Development and Manufacturing. Here, Andrea Allmendinger, Michael Adler and Hanns-Christian Mahler, all at ten23 health, highlight the importance of integrated drug product development, considering aspects such as formulation, device, container closure system, manufacturing processes and usability.
2023, February - Andrea Allmendinger and Hanns-Christian Mahler, talking about challenges in the commercialization of pre-filled syringes and injection devices.
2022 - Andrea Allmendinger and Hanns-Christian Mahler, talking about “How ten23 health is meeting developmental challenges for intravitreal products”.
2022, June - Hanns-Christian Mahler and Rainer Glöckler are talking about “Automating Aseptic Processing reduces Contamination Risk” in Pharmaceutical Technology.
2022, May - Susanne Jörg, our COO is talking about the relevance of Drug Product development and manufacturing for Biologics.
2022, April - Addressing the Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery.
2021, April - On “State-of-the-art solutions for ophthalmic sterile drug product manufacturing” with Rainer Glöckler and Carole Delauney.
Brochures / Reports
Download the ten23 health info brochure!
Download the ten23 health brochure with information on delivery of subcutaneous formulations.
Download the 2023 Fairstainability Report
Download the 2022 Fairstainability Report
Download the 2021 Fairstainability Report
Podcasts
Hanns-Christian Mahler talking with Raman Seghal in the Molecule to Market podcast
Hanns-Christian Mahler (CEO ten23 health) and Andrea Allmendinger (CSO ten23 health) talk about Biologic Drug Development and Manufacturing on this episode of Drug Solutions Podcast.